Effects of intravenous infusion of substance P on arginine vasopressin and oxytocin secretion in normal men.
In order to establish possible stimulatory effects of increasing plasma concentrations of substance P (SP) on the arginine vasopressin (AVP) and/or oxytocin (OT) secretion, successively increasing doses of SP(0.5, 1 and 1.5 pmol/kg-1/min-1; each dose for 20 min) were infused in 7 normal men. Plasma AVP and OT levels were measured before infusion and every 20 min, just before increasing the infusion dose of SP. During tests, SP infusion did not produce untoward side effects or changes in blood osmolality and/or pressure. Plasma OT levels did not change during SP infusion. Plasma AVP concentrations were not modified by the infusion of the lowest dose of SP, whereas they were significantly increased in a dose response fashion when higher amounts of SP were given. These findings demonstrate for the first time in humans that the systemic administration of SP exerts stimulatory effects on AVP, but not on OT secretion.
Chiodera
P
P
Department of Internal Medicine, School of Medicine, University of Parma, Italy.
Coiro
V
V
D000328:Adult; D001127:Arginine Vasopressin / Q000097:blood / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007262:Infusions, Intravenous; D007700:Kinetics; D008297:Male; D010121:Oxytocin / Q000097:blood / Q000378:metabolism*; D012016:Reference Values; D013373:Substance P / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors
D001127:Arginine Vasopressin; D013373:Substance P; D010121:Oxytocin